Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CFA Adjunct to NSPT in Chronic Periodontitis
NCT04623164Phase 4Completed
- Sponsor
- Vladikavkaz Scientific Center of the Russian Academy of Sciences
- Start
- Feb 2019
- Primary completion
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised, open-label trial of glycyrrhiza glabra, Vitano and eleuthero in chronic periodontitis (3 arms), sponsored by Vladikavkaz Scientific Center of the Russian Academy of Sciences. Primary endpoints: Periodontal Index (Russell) at 6 months and Sulcus Bleeding Index (Muhleman) at 6 months. Started Feb 2019; status: completed.
02
Drugs
glycyrrhiza glabraVitanoeleuthero
03
Conditions
chronic periodontitis
Beyond the preview
Go deeper on NCT04623164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04623164.